Drinking coffee may reduce the risk of chronic liver disease, especially in patients with other conditions affecting the liver, including non-alcoholic fatty liver disease, according…
News
A recent study has suggested that nonalcoholic fatty liver disease (NAFLD) may contribute to increased rates of hospital readmission in patients suffering from heart failure.
Focused ultrasound appears to be able to selectively destroy liver tumors, new research from an EU project shows. Preliminary results of this new method, developed…
The tiny spheres, or microvesicles (MVs), released from liver cells and macrophages seem to be key players in the progression of non-alcoholic fatty liver disease…
Using high doses of opioid pain killers while waiting for a liver transplant can increase the risk of death and organ loss after the transplant, showed a study published in the journal Liver Transplantation.
A compound found in broccoli sprouts apparently prevents obesity and fatty liver disease by boosting the amount of brown fat and improving the composition of gut bacteria…
Conducting too many liver tests in one go may cause unnecessary worry, biopsies and costs, according to scientists at the University of Michigan.
Combining the chemotherapy agent Sutent (sunitinib) and immunotherapy may be a promising strategy to fight hepatocellular carcinoma, the most common type of liver cancer, according…
A team of international researchers described a process by which the liver is able to burn up fats that accumulate as a result of non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. Based on this finding, the researchers developed a cocktail of substances that could trigger this process in the liver.
Consuming fructose, a sweetener used in processed foods and sodas, is an established risk factor for obesity and related metabolic diseases like Type 2 diabetes,…
Recent Posts
- Living with MASH reminds me to avoid making assumptions
- Particles in grilled meats may trigger liver disease, mouse study finds
- Supporting my oldest son, who’s growing up with a chronically ill sibling
- Human trial testing gene silencing injection therapy for MASH kicks off
- Blood bile acids predict liver outcomes in Alagille syndrome children: Study